Zydus recalls single lot of blood thinner warfarin

Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.

Zydus says it is recalling all of warfarin lot MM5767 with an expiration date of June 2014. The company says it has not received any reports of patient injury or harm.

Warfarin is a blood thinner widely used to prevent blood clots in patients with irregular heartbeats, or a history of heart attack. An overdose of could cause excessive bleeding and potentially be fatal.

The drugmaker says the affected products were distributed to wholesalers, retailers and mail order providers nationwide between November and December 2012.

Anyone with the product should stop selling or using it immediately and call 1-800-967-5952 to arrange its return to the manufacturer.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New blood thinner beats older drug for vein clots

Feb 20, 2013

(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...

Kcentra approved to stop severe bleeding in heart patients

Apr 30, 2013

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...

Recommended for you

EU regulator: Morning-after pill OK for all women

16 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

20 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

21 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments